Update
$Matinas BioPharma(MTNB.US$ Matinas BioPharma Successfully Reaches Agreement with FDA for a Single Phase 3 Registration Trial to Support an NDA for MAT2203 for the Treatment of Invasive Aspergillosis
5 MINUTES AGO, 7:30 AM EST
VIA GLOBENEWSWIRE
5 MINUTES AGO, 7:30 AM EST
VIA GLOBENEWSWIRE
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment